Skip to main content
. 2012 Sep 27;7(9):e44951. doi: 10.1371/journal.pone.0044951

Figure 5. Immunohistochemical analysis of CDO1 in colon and esophagus cancer tissue array. A.

Figure 5

, Strong expression of CDO1 in non-malignant colon tissues. The expression of CDO1 protein was positive in 6 out of 6 patients. NN1, a patient without cancer, and two more cases are shown in Figure S2A. B, A group of samples were derived from a single patient consist of colon adenocarcinomas (AD), matched cancer adjacent normal appearing tissue (NAT) and matched cancer adjacent tissues (Adjacent). CDO1 expression was investigated in a total of 36 groups of samples. Patients were numbered arbitrarily (Pt1 ∼ Pt3). CRC Pt1, a patient with CRC. Two more cases are shown in Figure S2B. C, CDO1 expression in ESCC. PT, ESCC; PN, matched normal appearing tissues. ESCC Pt1, a patient with ESCC. Three more cases are shown in Figure S2C. D, CDO1 expression in colon adenocarcinoma (AD) with different tumor grades. Mu-AD, mucinous adenocarcinomas. E, CDO1 expression in ESCC with different tumor grades. EAD, esophageal adenocarcinomas; Me-ESCC, metastatic ESCC.